Author:
Helgason H H,Kruijtzer C M F,Huitema A D R,Marcus S G,ten Bokkel Huinink W W,Schot M E,Schornagel J H,Beijnen J H,Schellens J H M
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Baker SD, Verweij J, Rowinsky EK, Donehower RC, Schellens JHM, Grochow LB, Sparreboom A (2002) Role of body surface area in dosing of investigational anticancer agents in adults, 1991–2001. J Natl Cancer Inst 94: 1883–1888
2. Bernard-Marty C, Cardoso F, Piccart MJ (2003) Use and abuse of taxanes in the management of metastatic breast cancer. Eur J Cancer 39: 1978–1989
3. Di Leo A, Piccart MJ (1999) Paclitaxel activity, dose, and schedule: data from phase III trials in metastatic breast cancer. Semin Oncol 26: 27–32
4. Feigelson HS, Henderson BE, Pike MC (1997) Re: Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 89: 1810–1812
5. Gelderblom H, Mross K, ten Tije AJ, Behringer D, Mielke S, van Zomeren DM, Verweij J, Sparreboom A (2002) Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions. J Clin Oncol 20: 574–581
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献